Mineralocorticoid Receptor Antagonist (MRA) Use Among CKD Patients Before and After the Transition to Dialysis: A Real-World Observation from an Integrated Health System
DOI:
10.1681/asn.20233411s1863b
Publication Date:
2024-05-18T03:23:26Z
AUTHORS (9)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....